グラヌロバキュラー変性および高位神経線維細胞の変性 双極性障害におけるブラック段階
Akito Nagakura1,2, Ito Kawakami1,2,3, Araki Kimura1,2,4
1Tokyo Metropolitan Matsuzawa Hospital, Tokyo, Japan.
Psychiatry and clinical neurosciences
|September 1, 2025
まとめ
神経変性プロセスは,タウ病変とCHMP2B陽性粒球変性 (GVD) を含むが,双極性障害 (BD) の患者のタラマスではより一般的です. これらの発見は,BDの病理生理学における神経変性の役割を示唆しています.
科学分野:
- 神経科学
- 神経病理学
- 精神科
背景:
- 皮質下タンパク質の蓄積は 気分障害と関連しています
- 二極性障害 (BD) の病理生理学には,パラベントリキュラー・タラミック核 (PVT) が関与している.
- BDにおけるタラミック神経病理学は十分に研究されていない.
研究 の 目的:
- 脊髄病の患者における 脊髄と中側側頭部 (海馬を含む) の神経変性病理を調べる
- タウ,アミロイド-β,α-シヌクレイン,TDP-43,および粒状血管変性 (GVD) マーカーの負担を調べる.
主な方法:
- 23人のBD患者と9人の対照群の死後の脳組織を分析した.
- 免疫ヒストケミストリーは,リン酸化タウ,アミロイド-β,α-シヌクレイン,TDP-43,およびGVDマーカー (CHMP2B,CK- 1δ) を検出するために使用されました.
主要な成果:
- ニューロフィブリラー・タングル・ブラック・ステージとアルギロフィリック・グラン・サイト・ステージを含む,BD症例は,タウ病変の有意に高い負担を示した.
- CHMP2B陽性GVDは,対照群と比較して,BD症例のPVTにおいて有意に多く見られた.
結論:
- PVTにおける神経変性プロセス,特にタウ病理およびCHMP2B陽性GVDは,BDの病理生理学に寄与する可能性があります.
- これらの発見は,BDに関連した気分症状におけるタラミック神経変性の潜在的な役割を強調しています.
関連する概念動画
Bipolar Disorder
142
Bipolar disorder is a chronic mental health condition marked by significant mood fluctuations, including episodes of mania and depression. Elevated energy levels, heightened mood or irritability, impulsive behavior, reduced sleep needs, rapid speech, racing thoughts, inflated self-esteem, and distractibility characterize mania. Individuals with bipolar disorder often alternate between depressive and manic states, with periods of emotional stability lasting an average of six months to a year.
142
Amyloid Fibrils
9.8K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.8K
Biological Causes of Schizophrenia
145
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
145
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
Long-term Depression
31.4K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
31.4K
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
945
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
945


